A DFT investigation of the adsorption mechanism of paclitaxel on functionalized graphene oxide for enhanced drug delivery
Abstract The development of effective drug delivery systems is vital for enhancing the therapeutic efficacy of anticancer agents, particularly paclitaxel (PTX). Despite its potent anticancer properties, PTX faces limitations due to poor solubility and non-specific distribution, leading to significan...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-99156-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850172790501539840 |
|---|---|
| author | Bader Huwaimel Saad Alqarni |
| author_facet | Bader Huwaimel Saad Alqarni |
| author_sort | Bader Huwaimel |
| collection | DOAJ |
| description | Abstract The development of effective drug delivery systems is vital for enhancing the therapeutic efficacy of anticancer agents, particularly paclitaxel (PTX). Despite its potent anticancer properties, PTX faces limitations due to poor solubility and non-specific distribution, leading to significant side effects. To address these challenges, researchers have explored the use of reduced graphene oxide (rGO) as a nanocarrier. Functionalized rGO exhibits unique physicochemical properties, including high surface area and biocompatibility, which enhance drug loading capacity. This study investigates the adsorption mechanisms of PTX on various functionalized rGO surfaces, utilizing computational methods such as Density Functional Theory and Molecular Dynamics simulations. The results demonstrate that functionalization with hydroxyl (-OH), carboxyl (-COOH), and sulfonic (-SO) groups significantly influences the adsorption energy and charge transfer characteristics of PTX on GO. The adsorption energies calculated for PTX@rGO-OH and PTX@rGO-COOH were found to be -0.76 eV and − 0.91 eV, respectively, indicating physisorption predominantly through hydrogen bonding. In contrast, PTX@rGO-SO exhibited a higher adsorption energy of -2.09 eV, suggesting chemisorption facilitated by stronger covalent interactions. The presence of these functional groups also enhanced the binding affinity and stability of the drug-nanocarrier complex. Charge transfer analysis revealed that the rGO-COOH and rGO-SO systems exhibited significant changes in electronic properties, with charge transfers estimated at -0.16e and − 0.08e, respectively. These results indicate enhanced electronic coupling between PTX and the functionalized rGO surfaces, which can improve drug loading efficiency and release kinetics. The study also highlights the importance of optimizing surface chemistry to maximize drug interactions, leading to improved therapeutic outcomes. In conclusion, the investigation underscores the potential of functionalized graphene oxide as a promising platform for drug delivery systems. The findings, including the adsorption energies and charge transfer data, provide valuable insights into the interactions between PTX and functionalized rGO, paving the way for the design of optimized nanocarriers capable of enhancing the efficacy of anticancer therapies. The continued exploration of these systems is essential for advancing the field of nanomedicine and improving treatment strategies for cancer patients. |
| format | Article |
| id | doaj-art-b7a9decc1bca4f9dae7cbb59a49f102c |
| institution | OA Journals |
| issn | 2045-2322 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-b7a9decc1bca4f9dae7cbb59a49f102c2025-08-20T02:19:58ZengNature PortfolioScientific Reports2045-23222025-04-0115112010.1038/s41598-025-99156-9A DFT investigation of the adsorption mechanism of paclitaxel on functionalized graphene oxide for enhanced drug deliveryBader Huwaimel0Saad Alqarni1Department of Pharmaceutical Chemistry, College of Pharmacy, University of Ha’ilDepartment of Pharmaceutical Chemistry, College of Pharmacy, University of Ha’ilAbstract The development of effective drug delivery systems is vital for enhancing the therapeutic efficacy of anticancer agents, particularly paclitaxel (PTX). Despite its potent anticancer properties, PTX faces limitations due to poor solubility and non-specific distribution, leading to significant side effects. To address these challenges, researchers have explored the use of reduced graphene oxide (rGO) as a nanocarrier. Functionalized rGO exhibits unique physicochemical properties, including high surface area and biocompatibility, which enhance drug loading capacity. This study investigates the adsorption mechanisms of PTX on various functionalized rGO surfaces, utilizing computational methods such as Density Functional Theory and Molecular Dynamics simulations. The results demonstrate that functionalization with hydroxyl (-OH), carboxyl (-COOH), and sulfonic (-SO) groups significantly influences the adsorption energy and charge transfer characteristics of PTX on GO. The adsorption energies calculated for PTX@rGO-OH and PTX@rGO-COOH were found to be -0.76 eV and − 0.91 eV, respectively, indicating physisorption predominantly through hydrogen bonding. In contrast, PTX@rGO-SO exhibited a higher adsorption energy of -2.09 eV, suggesting chemisorption facilitated by stronger covalent interactions. The presence of these functional groups also enhanced the binding affinity and stability of the drug-nanocarrier complex. Charge transfer analysis revealed that the rGO-COOH and rGO-SO systems exhibited significant changes in electronic properties, with charge transfers estimated at -0.16e and − 0.08e, respectively. These results indicate enhanced electronic coupling between PTX and the functionalized rGO surfaces, which can improve drug loading efficiency and release kinetics. The study also highlights the importance of optimizing surface chemistry to maximize drug interactions, leading to improved therapeutic outcomes. In conclusion, the investigation underscores the potential of functionalized graphene oxide as a promising platform for drug delivery systems. The findings, including the adsorption energies and charge transfer data, provide valuable insights into the interactions between PTX and functionalized rGO, paving the way for the design of optimized nanocarriers capable of enhancing the efficacy of anticancer therapies. The continued exploration of these systems is essential for advancing the field of nanomedicine and improving treatment strategies for cancer patients.https://doi.org/10.1038/s41598-025-99156-9DFTMolecular dynamicsPaclitaxelFunctionalized graphene oxideDrug delivery |
| spellingShingle | Bader Huwaimel Saad Alqarni A DFT investigation of the adsorption mechanism of paclitaxel on functionalized graphene oxide for enhanced drug delivery Scientific Reports DFT Molecular dynamics Paclitaxel Functionalized graphene oxide Drug delivery |
| title | A DFT investigation of the adsorption mechanism of paclitaxel on functionalized graphene oxide for enhanced drug delivery |
| title_full | A DFT investigation of the adsorption mechanism of paclitaxel on functionalized graphene oxide for enhanced drug delivery |
| title_fullStr | A DFT investigation of the adsorption mechanism of paclitaxel on functionalized graphene oxide for enhanced drug delivery |
| title_full_unstemmed | A DFT investigation of the adsorption mechanism of paclitaxel on functionalized graphene oxide for enhanced drug delivery |
| title_short | A DFT investigation of the adsorption mechanism of paclitaxel on functionalized graphene oxide for enhanced drug delivery |
| title_sort | dft investigation of the adsorption mechanism of paclitaxel on functionalized graphene oxide for enhanced drug delivery |
| topic | DFT Molecular dynamics Paclitaxel Functionalized graphene oxide Drug delivery |
| url | https://doi.org/10.1038/s41598-025-99156-9 |
| work_keys_str_mv | AT baderhuwaimel adftinvestigationoftheadsorptionmechanismofpaclitaxelonfunctionalizedgrapheneoxideforenhanceddrugdelivery AT saadalqarni adftinvestigationoftheadsorptionmechanismofpaclitaxelonfunctionalizedgrapheneoxideforenhanceddrugdelivery AT baderhuwaimel dftinvestigationoftheadsorptionmechanismofpaclitaxelonfunctionalizedgrapheneoxideforenhanceddrugdelivery AT saadalqarni dftinvestigationoftheadsorptionmechanismofpaclitaxelonfunctionalizedgrapheneoxideforenhanceddrugdelivery |